| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.044 | 0.4 |